| |
|
|
|
|
|
|
|||
|
Blood, 30 July 2009, Vol. 114, No. 5, pp. 931-932.
Bortezomib paradigm shift in myelomaMD ANDERSON CANCER CENTER Abstract
Bortezomib's unprecedented antitumor activity in myeloma has long been attributed to NF-
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||